1,112
Views
21
CrossRef citations to date
0
Altmetric
Review

Secondary neuroprotective effects of hypotensive drugs and potential mechanisms of action

&
Pages 161-175 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sunee Chansangpetch & Shan C Lin. (2018) Optical Coherence Tomography Angiography in Glaucoma Care. Current Eye Research 43:9, pages 1067-1082.
Read now

Articles from other publishers (20)

Mathew Timothy Artuz Manuel & Lemmuel L. Tayo. (2023) Navigating the Gene Co-Expression Network and Drug Repurposing Opportunities for Brain Disorders Associated with Neurocognitive Impairment. Brain Sciences 13:11, pages 1564.
Crossref
Astrianda Nadya Suryono. (2023) Neuroprotection in the Treatment of Glaucoma. MEDICINUS 36:2, pages 3-8.
Crossref
Carolina Nunes da Silva, Kenia Pedrosa Nunes, Lays Fernanda Nunes Dourado, Thayllon Oliveira Vieira, Xavier Maia Mariano, Armando da Silva Cunha Junior & Maria Elena de Lima. (2022) From the PnTx2-6 Toxin to the PnPP-19 Engineered Peptide: Therapeutic Potential in Erectile Dysfunction, Nociception, and Glaucoma. Frontiers in Molecular Biosciences 9.
Crossref
Jingyuan Zhu, Anoop Sainulabdeen, Krystal Akers, Vishnu Adi, Jeffrey R. Sims, Eva Yarsky, Yi Yan, Yu Yu, Hiroshi Ishikawa, Christopher K. Leung, Gadi Wollstein, Joel S. Schuman, Wenbin Wei & Kevin C. Chan. (2021) Oral Scutellarin Treatment Ameliorates Retinal Thinning and Visual Deficits in Experimental Glaucoma. Frontiers in Medicine 8.
Crossref
Mohd Aizuddin Mohd Lazaldin, Igor Iezhitsa, Renu Agarwal, Nor Salmah Bakar, Puneet Agarwal & Nafeeza Mohd Ismail. (2020) Neuroprotective effects of brain‐derived neurotrophic factor against amyloid beta 1‐40‐induced retinal and optic nerve damage. European Journal of Neuroscience 51:12, pages 2394-2411.
Crossref
Wendi S. Lambert, Silvia Pasini, John W. Collyer, Cathryn R. Formichella, Purnima Ghose, Brian J. Carlson & David J. Calkins. (2020) Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma. Scientific Reports 10:1.
Crossref
Lauren K. Wareham, Melissa L. Cooper & David J. Calkins. 2020. The Senses: A Comprehensive Reference. The Senses: A Comprehensive Reference 567 589 .
Ayumi Nakagawa, Osamu Sakai, Hideki Tokushige, Takashi Fujishiro & Makoto Aihara. (2019) Development and characterization of a new rat ocular hypertension model induced by intracameral injection of conjunctival fibroblasts. Scientific Reports 9:1.
Crossref
Lewis E. Fry, Eamonn Fahy, Vicki Chrysostomou, Flora Hui, Jessica Tang, Peter van Wijngaarden, Steven Petrou & Jonathan G. Crowston. (2018) The coma in glaucoma: Retinal ganglion cell dysfunction and recovery. Progress in Retinal and Eye Research 65, pages 77-92.
Crossref
Najam A. Sharif. (2018) i Drugs and i Devices Discovery Research: Preclinical Assays, Techniques, and Animal Model Studies for Ocular Hypotensives and Neuroprotectants . Journal of Ocular Pharmacology and Therapeutics 34:1-2, pages 7-39.
Crossref
Abram Akopian, Sandeep Kumar, Hariharasubramanian Ramakrishnan, Kaushambi Roy, Suresh Viswanathan & Stewart A. Bloomfield. (2017) Targeting neuronal gap junctions in mouse retina offers neuroprotection in glaucoma. Journal of Clinical Investigation 127:7, pages 2647-2661.
Crossref
I.L. Chereshnyuk, O.I. Alchuk, L.I. Marynych, R.A. Kravets, A.O. Ivanitsa & O.A. Khodakovskyi. (2017) EFFECT OF NMDA-RECEPTOR BLOCKERS ON THE DYNAMICS OF INTRAOCULAR PRESSURE IN RABBITS. Fiziolohichnyĭ zhurnal 63:1, pages 69-76.
Crossref
H. Kauser, S. Sahu & U. Panjwani. (2016) Guanfacine promotes neuronal survival in medial prefrontal cortex under hypobaric hypoxia. Brain Research 1636, pages 152-160.
Crossref
Tanuj Dada, Parul Ichhpujani, Srinivasan Senthilkumari & Alain Bron. 2016. Pharmacology of Ocular Therapeutics. Pharmacology of Ocular Therapeutics 207 227 .
Sarah L. Greig & Emma D. Deeks. (2015) Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension. Drugs & Aging 32:3, pages 251-260.
Crossref
Wendi S. Lambert, Brian J. Carlson, Alice E. van der Ende, Grace Shih, Julia N. Dobish, David J. Calkins & Eva Harth. (2015) Nanosponge-Mediated Drug Delivery Lowers Intraocular Pressure. Translational Vision Science & Technology 4:1, pages 1.
Crossref
Yi-Ing Chen, Yih-Jing Lee, David A. Wilkie & Chung-Tien Lin. (2014) Evaluation of potential topical and systemic neuroprotective agents for ocular hypertension-induced retinal ischemia-reperfusion injury. Veterinary Ophthalmology 17:6, pages 432-442.
Crossref
Pan‐Pan Tan, Hai‐Hong Yuan, Xu Zhu, Yong‐Yao Cui, Hui Li, Xue‐Mei Feng, Yu Qiu, Hong‐Zhuan Chen & Wei Zhou. (2013) Activation of Muscarinic Receptors Protects against Retinal Neurons Damage and Optic Nerve Degeneration In Vitro and In Vivo Models . CNS Neuroscience & Therapeutics 20:3, pages 227-236.
Crossref
Jason D. Dapper, Samuel D. Crish, Iok-Hou Pang & David J. Calkins. (2013) Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy. Neurobiology of Disease 59, pages 26-37.
Crossref
Norbert Pfeiffer, Julia Lamparter, Adrian Gericke, Franz H. Grus, Esther M. Hoffmann & Jochen Wahl. (2013) Neuroprotection of medical IOP-lowering therapy. Cell and Tissue Research 353:2, pages 245-251.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.